We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Commercial Kit Enables Rapid Assessment of Chromatin Structure

By LabMedica International staff writers
Posted on 13 Feb 2011
A commercial kit is now available that enables the rapid quantitative assessment of chromatin structure by quantitatively differentiating expressed (accessible) and silent (inaccessible) regions of the genome.

The Bio-Rad Laboratories (Hercules, CA, USA) EpiQ chromatin analysis kit was designed to complement existing epigenetic assays such as DNA methylation and chromatin immunoprecipitation. More...
These measurements detect whether epigenetic processes such as DNA methylation or histone modification have caused changes in gene expression.

The EpiQ chromatin analysis kit was designed to differentiate between genes that are being actively transcribed (euchromatin) and silent genes (heterochromatin). The selective nuclease provided in the kit can only act on euchromatin. The difference in the amount of DNA detected by the kit's PCR reagents before and after nuclease digestion reveals the extent to which the target gene is expressed.

The EpiQ kit includes buffers for cell permeabilization and in situ chromatin digestion, optimized nuclease, materials for genomic DNA purification, control assays (qPCR primers) for chromatin assessment of a reference (epigenetically silenced) and control (constitutively expressed) gene, and EpiQ Chromatin SYBR Green Supermix, a real-time PCR reagent designed to amplify genomic DNA.

The EpiQ kit permits assessment of chromatin structure in as few as 50,000 cultured cells within six hours, and it can generate quantitative chromatin structure information for multiple genomic elements.

"The EpiQ chromatin analysis kit provides researchers with an easy and fast way to quantify a gene's chromatin state,” said Viresh Patel, marketing manager for PCR reagents at Bio-Rad. "Using the kit, cancer, developmental, and stem cell biology researchers are able to glean direct information regarding the chromatin state that is associated with epigenetic marks such as DNA methylation and histone modifications for the first time."

Related Links:
Bio-Rad Laboratories



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.